CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 78 filers reported holding CITIUS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,346 | -51.2% | 19,500 | -15.9% | 0.00% | – |
| Q2 2023 | $27,376 | +136780.0% | 23,200 | +35.7% | 0.00% | – |
| Q1 2023 | $20 | -25.9% | 17,100 | -49.7% | 0.00% | – |
| Q4 2022 | $27 | -99.9% | 34,000 | +16.8% | 0.00% | – |
| Q3 2022 | $37,000 | -24.5% | 29,100 | +3.5% | 0.00% | – |
| Q1 2022 | $49,000 | – | 28,114 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Inspire Advisors, LLC | 188,796 | $291,000 | 0.08% |
| Horst & Graben Wealth Management LLC | 75,722 | $117,000 | 0.03% |
| Alpine Global Management, LLC | 83,475 | $129,000 | 0.02% |
| Miller Investment Management, LP | 50,000 | $77,000 | 0.01% |
| SABBY MANAGEMENT, LLC | 30,863 | $48,000 | 0.01% |
| WILBANKS SMITH & THOMAS ASSET MANAGEMENT LLC | 49,075 | $76,000 | 0.00% |
| Alberta Investment Management Corp | 172,185 | $265,000 | 0.00% |
| Syverson Strege & Co | 2,145 | $3,000 | 0.00% |
| HighTower Advisors, LLC | 170,623 | $263,000 | 0.00% |
| HRT FINANCIAL LP | 90,871 | $139,000 | 0.00% |